EP1854874A1 - Method and device for injecting a solution into a cell - Google Patents

Method and device for injecting a solution into a cell Download PDF

Info

Publication number
EP1854874A1
EP1854874A1 EP20070105503 EP07105503A EP1854874A1 EP 1854874 A1 EP1854874 A1 EP 1854874A1 EP 20070105503 EP20070105503 EP 20070105503 EP 07105503 A EP07105503 A EP 07105503A EP 1854874 A1 EP1854874 A1 EP 1854874A1
Authority
EP
European Patent Office
Prior art keywords
pressure
valve
solution
capillary
regulator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP20070105503
Other languages
German (de)
French (fr)
Other versions
EP1854874B1 (en
Inventor
Kiyoshi Taninaka
Jun Sasaki
Akihiko Yabuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujitsu Ltd
Original Assignee
Fujitsu Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujitsu Ltd filed Critical Fujitsu Ltd
Publication of EP1854874A1 publication Critical patent/EP1854874A1/en
Application granted granted Critical
Publication of EP1854874B1 publication Critical patent/EP1854874B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/89Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M35/00Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/12Means for regulation, monitoring, measurement or control, e.g. flow regulation of temperature
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M41/00Means for regulation, monitoring, measurement or control, e.g. flow regulation
    • C12M41/40Means for regulation, monitoring, measurement or control, e.g. flow regulation of pressure
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/10Devices for transferring samples or any liquids to, in, or from, the analysis apparatus, e.g. suction devices, injection devices
    • G01N35/1009Characterised by arrangements for controlling the aspiration or dispense of liquids
    • G01N35/1016Control of the volume dispensed or introduced
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/10Devices for transferring samples or any liquids to, in, or from, the analysis apparatus, e.g. suction devices, injection devices
    • G01N35/1095Devices for transferring samples or any liquids to, in, or from, the analysis apparatus, e.g. suction devices, injection devices for supplying the samples to flow-through analysers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T137/00Fluid handling
    • Y10T137/206Flow affected by fluid contact, energy field or coanda effect [e.g., pure fluid device or system]
    • Y10T137/218Means to regulate or vary operation of device
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T137/00Fluid handling
    • Y10T137/206Flow affected by fluid contact, energy field or coanda effect [e.g., pure fluid device or system]
    • Y10T137/218Means to regulate or vary operation of device
    • Y10T137/2202By movable element
    • Y10T137/2218Means [e.g., valve] in control input

Definitions

  • the present invention generally relates to injecting material into cells.
  • a microinjection device is used for injecting a solution (usually a medicinal solution) into a cell.
  • a solution usually a medicinal solution
  • Fig. 6 is an example of a conventional device.
  • reference numeral 1 denotes a positive pressure pump
  • reference numeral 2 denotes a negative pressure pump
  • Reference numeral 3 denotes a regulator that is connected to the positive pressure pump 1 and the negative pressure pump 2 for keeping constant the internal pressures thereof.
  • Reference numeral 4 denotes a capillary that discharges a solution into a cell due to the pressure from the regulator 3.
  • the capillary 4 is similar to an injection syringe, and has a fine needle at its tip.
  • the internal diameter of the tip is 0.5 ⁇ m and the external diameter is 1 ⁇ m.
  • Reference numeral 6 denotes a tube that transmits the pressure from the regulator 3 to the capillary 4, and reference numeral 5 denotes a pressure sensor which is located in the middle of the tube 6.
  • the pressure detected by the pressure sensor 5 is output to the regulator 3, and the regulator 3 adjusts the internal pressure so that the pressure detected by the pressure sensor 5 is maintained constant. Otherwise, it is possible to arrange the pressure sensor inside the regulator 3 and adjust the internal pressure so as to maintain constant output from the pressure sensor. Electric voltage is input to the regulator 3 as a control signal, and the regulator 3 generates a pressure that is proportional to the input electric voltage.
  • the needle attached to the tip of the capillary 4 is filled with the solution.
  • Pressure applied by the regulator 3 urges a cylinder of the capillary 4 whereby the solution is discharged (injected) into the cell.
  • the cell is observed for a change that occurs after injection of the solution.
  • Fig. 7 depicts a pressure response curve of the conventional device.
  • a horizontal axis indicates time and a vertical axis indicates pressure.
  • the pressure is maintained at a reverse flow preventing pressure.
  • the pressure reaches an injection pressure, and the capillary 4 injects the solution into the cell.
  • the state in which the capillary 4 is injected into the cell continues for a predetermined period after which the pressure is lowered gradually.
  • the injecting operation stops when the pressure reaches the reverse flow preventing pressure.
  • the conventional device can be used in a gene delivery device.
  • cells that flow through a micro fluid channel are observed by using a cell observing device, cells are trapped one by one with a cell trapping device, and genetic material and medicinal solutions are discharged into the cells by using a gene delivering micro needle (for example, see Japanese Patent Application Laid-Open No. 2004-166653 ).
  • a microinjection apparatus has, at its tip, a micro instrument that is connected to a micro syringe, which is filled with the solution. When a male screw is rotated to move a plunger, into the micro syringe, the solution is discharged from the micro instrument (for example, see Japanese Patent Application Laid-Open No. H03-119989 ).
  • a microinjecting method of the microinjection apparatus involves filling a predetermined volume of a solution in an extra fine capillary, with a tip that is of ⁇ m order of size, injecting the solution into the cell by pressurizing the capillary, and observing the response. In this process, it is necessary to control sequentially switching of the pressure between a pressure necessary for discharging the solution in the cell and a pressure necessary for preventing reverse flow of the solution into the capillary.
  • the conventional microinjection device which has the structure shown in Fig. 6, does not take into account the pressure transient response. Therefore, when trace quantity of solution of pl (picolitre) order is to be discharged through injections such as injections into animal cells, if the delivery time is lowered to less than 1 second for speeding a discharge cycle, the set pressure and the set time deviate from the actual response, and adjustment of discharging volume of the solution is difficult.
  • a solution discharging method for discharging a solution, from a hollow capillary with a narrow tip that is filled with the solution, into a cell due to an action of gas pressure includes connecting a regulating chamber to the capillary by a valve; and regulating gas in the regulating chamber at a predetermined pressure before opening and closing the valve so that regulated pressure has a generally rectangular waveform thereby controlling quantity of the solution that is to be injected from the capillary into the cell to be constant.
  • a microinjection device includes a pressure pump; a regulator that is connected to the pressure pump and that maintains constant pressure; a regulating chamber that is connected to the regulator and an internal pressure of which is maintained to a predetermined pressure; a valve that is connected to the regulating chamber; and a capillary that is connected to the valve and that is used to inject solution in a cell.
  • Fig. 1 is a schematic of a first embodiment of the present invention. Components that are same as those shown in Fig. 6 are indicated with the same reference numerals.
  • reference numeral 1 denotes a positive pressure pump
  • reference numeral 2 denotes a negative pressure pump
  • Reference numeral 3 denotes a regulator that regulates the pressure
  • reference numeral 10 denotes a regulating chamber that contains a gas (typically air) whose pressure is regulated by the regulator 3.
  • Reference numeral 5 denotes a second pressure sensor that detects pressure in the regulating chamber 10. The output of the second pressure sensor 5 is input in the regulator 3.
  • Reference numeral 4 denotes a capillary that injects solution into an animal cell and the like
  • reference numeral 11 denotes a valve arranged in between the regulating chamber 10 and the capillary 4.
  • the valve 11, the construction of which may include a solenoid for example, is opened and closed to transmit air from the regulating chamber 10 to the capillary 4.
  • Reference numeral 12 denotes a pressure sensor 1 that detects pressure of air in the capillary 4.
  • the pressure of air inside the capillary 4 is P 1
  • the volume is V 1 . Operation of the apparatus, which has such a configuration, is explained below.
  • pressure of the regulating chamber 10 is set by the regulator 3 to a certain degree higher than the injection pressure.
  • the operator while watching under a microscope, confirms that a needle of the capillary 4 reaches the cell, the operator opens the valve 11 to bring the pressure to injection pressure level.
  • the valve 11 is immediately closed. While the capillary 4 is discharging (injecting) the solution into the cell, the regulator 3 adjusts pressure in the regulating chamber 10 and sets it to a lower level than the reverse flow preventing pressure.
  • the pressure P after the opening of the valve is set in advance
  • the pressure P 1 in the capillary before the opening of the valve is known in advance from an output from the pressure sensor 12; therefore, it is possible to calculate the pressure P 2 of the regulator before the opening of the valve through Equation (3).
  • the pressure P 2 of the regulator before the opening of the valve is set to the value derived through Equation (3)
  • the pressure at the time of opening of the valve 11 is regulated to the pressure P. That is, it is possible to maintain the pressure in the regulating chamber and the capillary.
  • FIG. 7 Pressure response in an ordinary microinjection device is as shown in Fig. 7.
  • Fig. 2 is a graph for explaining the pressure response according to the present invention.
  • the horizontal axis is time and the vertical axis is the pressure.
  • the time interval required for responding to regulation of the pressure to the injection pressure level is still shorter than the response as shown in Fig. 7.
  • Fig. 7 in the characteristic of the conventional device, the time required to attain target value is longer, whereas the transient response of the device in the present invention is only represented by vibrations near the target value. If the integration value of the vibrations is considered zero, it can be thought that the total quantity of injecting solution is proportional to a product of the target pressure and the time required for application of the pressure.
  • a valve is arranged in between a regulating chamber and a capillary, and opened and closed to control the discharging quantity of solution from the capillary into a cell. That is, when the solution is injected into a cell, the quantity of solution can be easily controlled, and stable microinjection can be performed at high speed with less effect of transient response.
  • speedy rise of pressure in the capillary produces a roughly rectangular waveform that results in a high degree of accuracy in time required for application of the pressure, high speed injection cycle, and improved accuracy of the quantity of the injecting solution.
  • the quantity of the injecting solution is proportional to pressure and time for which the pressure is applied; therefore, even if there is transient response, a method of controlling the quantity of the injecting solution according to the pressure time integration also has the same effect on the accuracy of the quantity of the injecting solution. That is, according to the present invention, because the integration value of the pressure applied to the capillary and the time for which the pressure is applied is controlled to a predetermined value, it is possible to always control the quantity of the injecting solution to a constant quantity.
  • Fig. 3 is a schematic of a second embodiment according to the present invention. Components that are same as those in Fig. 1 are indicated with the same reference numerals.
  • the embodiment includes a second valve 15 in between the regulator 3 and the regulating chamber 10. Other aspects of the structure are same as shown in Fig. 1. In such a structure when the first valve 11 is opened and closed, the second valve 15 is kept closed, which prevents pressure fluctuations from being conveyed to the regulator 3 and prevents occurrence of fluctuation in pressure.
  • Fig. 4 is a schematic of a third embodiment according to the present invention. Components that are same as those in Fig. 3 are indicated with the same reference numerals.
  • reference numeral 25 denotes a second valve, which is connected to the regulator 3;
  • reference numeral 20 denotes a second regulating chamber connected to the second valve;
  • reference numeral 21 denotes a fourth valve that is connected to the second regulating chamber.
  • Reference numeral 22 denotes a pressure sensor that detects a pressure Pi in the first regulating chamber, and reference numeral 23 denotes a pressure sensor that detects a pressure Pc in the second regulating chamber.
  • Reference numeral 12 denotes a pressure sensor that detects the pressure in the capillary.
  • Reference numeral 15 denotes the first valve
  • reference numeral 10 denotes the first regulating chamber connected to the first valve
  • reference numeral 11 denotes a third valve connected to the first regulating chamber.
  • the first valve and the second valve are commonly connected to the regulator 3, and the third valve and the fourth valve are commonly connected to the capillary 4.
  • a double system of regulator units formed of valves regulators, and valves.
  • the third valve is closed, and the capillary 4 is injecting the solution in the cell, there is no need to regulate the regulating chamber 10. That is, when one system is operating the capillary 4, another system regulates the regulating chamber, and when injection operation of the capillary 4 is completed, opening of the fourth valve leads to a faster regulation after the opening of the valve.
  • time required to switch valves from one state to another is shortened.
  • Fig. 5 is a schematic of a fourth embodiment according to the present invention. Components that are same as those in Fig. 4 are indicated with the same reference numerals.
  • the embodiment includes a second regulator 30 corresponding to the second regulation system shown in Fig. 4.
  • the second regulator 30 is connected to the positive pump 1 and the negative pump 2, and is independent of a first regulator 3.
  • the second regulator 30 is connected to the second valve. Remaining structure is the same as that shown in Fig. 4.
  • Such a structure allows the regulator 3 and a regulator 30 to adjust the air pressure in the regulator chamber independently, which allows the two systems to operate independently, and this structure operates faster than the one shown in Fig. 4.
  • high accuracy of time for which pressure is applied can be achieved due to fast rise in pressure response that creates a generally rectangular waveform, and it is possible to have faster injection cycle and improve accuracy in quantity of discharging solution.

Abstract

A microinjection device includes a pressure pump (1, 2) and a regulator (3) that is connected to the pressure pump and that maintains constant pressure. A regulating chamber (10) is connected to the regulator (3) and an internal pressure of the regulating chamber is maintained to a predetermined pressure. A valve (11) is connected to the regulating chamber (10) and a hollow capillary (4) is connected to the valve. An operator opens/closes the valve (11) in the process of injecting material into a cell.

Description

  • The present invention generally relates to injecting material into cells.
  • In the field of new drug designing, a microinjection device is used for injecting a solution (usually a medicinal solution) into a cell. Fig. 6 is an example of a conventional device. As shown in the diagram, reference numeral 1 denotes a positive pressure pump, and reference numeral 2 denotes a negative pressure pump. Reference numeral 3 denotes a regulator that is connected to the positive pressure pump 1 and the negative pressure pump 2 for keeping constant the internal pressures thereof.
  • Reference numeral 4 denotes a capillary that discharges a solution into a cell due to the pressure from the regulator 3. The capillary 4 is similar to an injection syringe, and has a fine needle at its tip. The internal diameter of the tip is 0.5 µm and the external diameter is 1 µm. Reference numeral 6 denotes a tube that transmits the pressure from the regulator 3 to the capillary 4, and reference numeral 5 denotes a pressure sensor which is located in the middle of the tube 6.
  • The pressure detected by the pressure sensor 5 is output to the regulator 3, and the regulator 3 adjusts the internal pressure so that the pressure detected by the pressure sensor 5 is maintained constant. Otherwise, it is possible to arrange the pressure sensor inside the regulator 3 and adjust the internal pressure so as to maintain constant output from the pressure sensor. Electric voltage is input to the regulator 3 as a control signal, and the regulator 3 generates a pressure that is proportional to the input electric voltage.
  • The needle attached to the tip of the capillary 4 is filled with the solution. Pressure applied by the regulator 3 urges a cylinder of the capillary 4 whereby the solution is discharged (injected) into the cell. The cell is observed for a change that occurs after injection of the solution. When the pressure inside the regulator 3 is to be brought back to the atmospheric pressure, air is pulled out from the regulator 3 by the negative pressure pump 2 whereby the pressure inside the regulator 3 is quickly brought back to the atmospheric pressure.
  • Fig. 7 depicts a pressure response curve of the conventional device. A horizontal axis indicates time and a vertical axis indicates pressure. Initially, the pressure is maintained at a reverse flow preventing pressure. After time T1 is elapsed, the pressure reaches an injection pressure, and the capillary 4 injects the solution into the cell. The state in which the capillary 4 is injected into the cell continues for a predetermined period after which the pressure is lowered gradually. The injecting operation stops when the pressure reaches the reverse flow preventing pressure.
  • The conventional device can be used in a gene delivery device. In the gene delivery device, cells that flow through a micro fluid channel are observed by using a cell observing device, cells are trapped one by one with a cell trapping device, and genetic material and medicinal solutions are discharged into the cells by using a gene delivering micro needle (for example, see Japanese Patent Application Laid-Open No. 2004-166653 ). Furthermore, a microinjection apparatus has, at its tip, a micro instrument that is connected to a micro syringe, which is filled with the solution. When a male screw is rotated to move a plunger, into the micro syringe, the solution is discharged from the micro instrument (for example, see Japanese Patent Application Laid-Open No. H03-119989 ).
  • A microinjecting method of the microinjection apparatus involves filling a predetermined volume of a solution in an extra fine capillary, with a tip that is of µm order of size, injecting the solution into the cell by pressurizing the capillary, and observing the response. In this process, it is necessary to control sequentially switching of the pressure between a pressure necessary for discharging the solution in the cell and a pressure necessary for preventing reverse flow of the solution into the capillary.
  • However, the conventional microinjection device, which has the structure shown in Fig. 6, does not take into account the pressure transient response. Therefore, when trace quantity of solution of pl (picolitre) order is to be discharged through injections such as injections into animal cells, if the delivery time is lowered to less than 1 second for speeding a discharge cycle, the set pressure and the set time deviate from the actual response, and adjustment of discharging volume of the solution is difficult.
  • Therefore, using the conventional microinjection apparatus, an experienced operator would adjust the pressure and the time for applying the pressure while taking into account swelling of the cell when injecting the solution into the cell. However, in this method, it is unclear whether a constant amount of material is discharged into the cell.
  • It is desirable to at least partially solve the problems in the conventional technology.
  • According to an aspect of the present invention, a solution discharging method for discharging a solution, from a hollow capillary with a narrow tip that is filled with the solution, into a cell due to an action of gas pressure, includes connecting a regulating chamber to the capillary by a valve; and regulating gas in the regulating chamber at a predetermined pressure before opening and closing the valve so that regulated pressure has a generally rectangular waveform thereby controlling quantity of the solution that is to be injected from the capillary into the cell to be constant.
  • According to another aspect of the present invention, a microinjection device includes a pressure pump; a regulator that is connected to the pressure pump and that maintains constant pressure; a regulating chamber that is connected to the regulator and an internal pressure of which is maintained to a predetermined pressure; a valve that is connected to the regulating chamber; and a capillary that is connected to the valve and that is used to inject solution in a cell.
  • The above and other features, advantages and technical and industrial significance of this invention will be better understood by reading the following detailed description of presently preferred embodiments of the invention, when considered in connection with the accompanying drawings, in which:
    • Fig. 1 is a schematic of a first embodiment according to the present invention;
    • Fig. 2 is a graph for explaining a pressure response according to the present invention;
    • Fig. 3 is a schematic of a second embodiment according to the present invention;
    • Fig. 4 is a schematic of a third embodiment according to the present invention;
    • Fig. 5 is a schematic of a fourth embodiment according to the present invention;
    • Fig. 6 is a schematic of an example of the structure of a conventional device; and
    • Fig. 7 is a graph for explaining a pressure response of the conventional device.
  • Exemplary embodiments of the present invention are explained below in detail with reference to the accompanying drawings. Fig. 1 is a schematic of a first embodiment of the present invention. Components that are same as those shown in Fig. 6 are indicated with the same reference numerals. As shown in the diagram, reference numeral 1 denotes a positive pressure pump, and reference numeral 2 denotes a negative pressure pump. Reference numeral 3 denotes a regulator that regulates the pressure, reference numeral 10 denotes a regulating chamber that contains a gas (typically air) whose pressure is regulated by the regulator 3. Reference numeral 5 denotes a second pressure sensor that detects pressure in the regulating chamber 10. The output of the second pressure sensor 5 is input in the regulator 3.
  • Pressure of air in the regulating chamber 10 is P2 and volume is V2. Reference numeral 4 denotes a capillary that injects solution into an animal cell and the like, reference numeral 11 denotes a valve arranged in between the regulating chamber 10 and the capillary 4. The valve 11, the construction of which may include a solenoid for example, is opened and closed to transmit air from the regulating chamber 10 to the capillary 4. Reference numeral 12 denotes a pressure sensor 1 that detects pressure of air in the capillary 4. The pressure of air inside the capillary 4 is P1, and the volume is V1. Operation of the apparatus, which has such a configuration, is explained below.
  • First, pressure of the regulating chamber 10 is set by the regulator 3 to a certain degree higher than the injection pressure. When an operator, while watching under a microscope, confirms that a needle of the capillary 4 reaches the cell, the operator opens the valve 11 to bring the pressure to injection pressure level. When the pressure reaches the injection pressure level, the valve 11 is immediately closed. While the capillary 4 is discharging (injecting) the solution into the cell, the regulator 3 adjusts pressure in the regulating chamber 10 and sets it to a lower level than the reverse flow preventing pressure.
  • Afterwards, when the valve 11 is opened, pressure in the regulating chamber 10 and the capillary 4 becomes equal to the reverse flow preventing pressure, which prevents the solution from reverting into the capillary 4. The regulating chamber 10 is set to lower than the reverse flow preventing pressure in advance, which makes it possible to bring the level of the pressure entirely to the reverse flow preventing pressure, when the valve 11 is opened.
  • The relationship between the pressure before the opening of the valve and the pressure after the opening of the valve can be obtained through an equation of state of air. When P denotes pressure after the opening of the valve, P1 denotes pressure in the capillary before the opening of the valve, P2 denotes pressure in the regulator before the opening of the valve, V1 denotes volume of air in the capillary, and V2 denotes volume of air in the regulator, the pressure P after opening of the valve and volume ratio r\(=V1/V2) are represented with following equations: P = ( ηP 1 + P 2 ) / η + 1 )
    Figure imgb0001
    η = V 1 / V 2 = ( P - P 2 ) / P 1 - P
    Figure imgb0002
    With the help of Equation 1, the pressure P2 of the regulator before opening of the valve is represented with the following equation: P 2 = η + 1 P - ηP 1
    Figure imgb0003
    η can be calculated from Equation 2. Moreover, the pressure P after the opening of the valve is set in advance, the pressure P1 in the capillary before the opening of the valve is known in advance from an output from the pressure sensor 12; therefore, it is possible to calculate the pressure P2 of the regulator before the opening of the valve through Equation (3). When the pressure P2 of the regulator before the opening of the valve is set to the value derived through Equation (3), the pressure at the time of opening of the valve 11 is regulated to the pressure P. That is, it is possible to maintain the pressure in the regulating chamber and the capillary.
  • Pressure response in an ordinary microinjection device is as shown in Fig. 7. On the other hand, when the valve is switched from one state to another state in an instant, the pressure is transmitted at a sonic speed. The pressure response in such a case is as shown in a graph in Fig. 2. Fig. 2 is a graph for explaining the pressure response according to the present invention. The horizontal axis is time and the vertical axis is the pressure.
  • When the valve 11 is opened, the pressure rises from the reverse flow preventing pressure up to the injection pressure. Subsequently, when the valve 11 is closed, as shown in the diagram, the pressure drops to the reverse flow preventing pressure from the injection pressure in an instant. Rise and fall of the pressure is faster than the characteristic of the conventional device in Fig. 7.
  • As shown in the diagram, although some degree of transient response occurs due to reflection, the time interval required for responding to regulation of the pressure to the injection pressure level is still shorter than the response as shown in Fig. 7. As shown by Fig. 7 in the characteristic of the conventional device, the time required to attain target value is longer, whereas the transient response of the device in the present invention is only represented by vibrations near the target value. If the integration value of the vibrations is considered zero, it can be thought that the total quantity of injecting solution is proportional to a product of the target pressure and the time required for application of the pressure.
  • Thus, according to the first embodiment, a valve is arranged in between a regulating chamber and a capillary, and opened and closed to control the discharging quantity of solution from the capillary into a cell. That is, when the solution is injected into a cell, the quantity of solution can be easily controlled, and stable microinjection can be performed at high speed with less effect of transient response. According to the first embodiment, speedy rise of pressure in the capillary produces a roughly rectangular waveform that results in a high degree of accuracy in time required for application of the pressure, high speed injection cycle, and improved accuracy of the quantity of the injecting solution.
  • Generally, the quantity of the injecting solution is proportional to pressure and time for which the pressure is applied; therefore, even if there is transient response, a method of controlling the quantity of the injecting solution according to the pressure time integration also has the same effect on the accuracy of the quantity of the injecting solution. That is, according to the present invention, because the integration value of the pressure applied to the capillary and the time for which the pressure is applied is controlled to a predetermined value, it is possible to always control the quantity of the injecting solution to a constant quantity.
  • Fig. 3 is a schematic of a second embodiment according to the present invention. Components that are same as those in Fig. 1 are indicated with the same reference numerals. The embodiment includes a second valve 15 in between the regulator 3 and the regulating chamber 10. Other aspects of the structure are same as shown in Fig. 1. In such a structure when the first valve 11 is opened and closed, the second valve 15 is kept closed, which prevents pressure fluctuations from being conveyed to the regulator 3 and prevents occurrence of fluctuation in pressure.
  • Fig. 4 is a schematic of a third embodiment according to the present invention. Components that are same as those in Fig. 3 are indicated with the same reference numerals. In the diagram, reference numeral 25 denotes a second valve, which is connected to the regulator 3; reference numeral 20 denotes a second regulating chamber connected to the second valve; and reference numeral 21 denotes a fourth valve that is connected to the second regulating chamber. Reference numeral 22 denotes a pressure sensor that detects a pressure Pi in the first regulating chamber, and reference numeral 23 denotes a pressure sensor that detects a pressure Pc in the second regulating chamber. Reference numeral 12 denotes a pressure sensor that detects the pressure in the capillary.
  • Reference numeral 15 denotes the first valve, reference numeral 10 denotes the first regulating chamber connected to the first valve, and reference numeral 11 denotes a third valve connected to the first regulating chamber. The first valve and the second valve are commonly connected to the regulator 3, and the third valve and the fourth valve are commonly connected to the capillary 4.
  • Thus, according to the third embodiment, there is provided a double system of regulator units formed of valves regulators, and valves. In this structure, while the third valve is closed, and the capillary 4 is injecting the solution in the cell, there is no need to regulate the regulating chamber 10. That is, when one system is operating the capillary 4, another system regulates the regulating chamber, and when injection operation of the capillary 4 is completed, opening of the fourth valve leads to a faster regulation after the opening of the valve. Thus, according to the third embodiment, time required to switch valves from one state to another is shortened.
  • Fig. 5 is a schematic of a fourth embodiment according to the present invention. Components that are same as those in Fig. 4 are indicated with the same reference numerals. The embodiment includes a second regulator 30 corresponding to the second regulation system shown in Fig. 4. The second regulator 30 is connected to the positive pump 1 and the negative pump 2, and is independent of a first regulator 3. The second regulator 30 is connected to the second valve. Remaining structure is the same as that shown in Fig. 4.
  • Such a structure allows the regulator 3 and a regulator 30 to adjust the air pressure in the regulator chamber independently, which allows the two systems to operate independently, and this structure operates faster than the one shown in Fig. 4.
  • Thus, according to an aspect of the present invention, high accuracy of time for which pressure is applied can be achieved due to fast rise in pressure response that creates a generally rectangular waveform, and it is possible to have faster injection cycle and improve accuracy in quantity of discharging solution.
  • Although the invention has been described with respect to a specific embodiment for a complete and clear disclosure, the appended claims are not to be thus limited but are to be construed as embodying all modifications and alternative constructions that may occur to one skilled in the art that fairly fall within the basic teaching herein set forth.

Claims (7)

  1. A solution discharging method for discharging a solution, from a hollow capillary with a narrow tip that is filled with the solution, into a cell due to an action of air pressure, the solution discharging method comprising:
    connecting a regulating chamber to the capillary by a valve; and
    regulating air in the regulating chamber at a predetermined pressure before opening and closing the valve so that regulated pressure has a rectangular waveform thereby controlling quantity of the solution that is to be injected from the capillary into the cell to be constant.
  2. The solution discharging method according to claim 1, wherein an integration value of pressure applied to the capillary and time for which the pressure is applied is controlled to a predetermined value thereby controlling the quantity of the solution that is to be injected into the cell.
  3. A microinjection device comprising:
    a pressure pump;
    a regulator that is connected to the pressure pump and that maintains constant pressure;
    a regulating chamber that is connected to the regulator and an internal pressure of which is maintained to a predetermined pressure;
    a valve that is connected to the regulating chamber; and
    a capillary that is connected to the valve and that is used to inject solution in a cell.
  4. The microinjection device according to claim 3, wherein after the valve is opened, the internal pressure of the regulating chamber is regulated to a lower pressure than a reverse flow preventing pressure by closing the valve while the solution is being injected into the cell.
  5. The microinjection device according to claim 3, further comprising a second valve that is located between the regulator and the regulating chamber.
  6. The microinjection device according to claim 3, wherein the regulator includes a double system of regulators to maintain a predetermined pressure that is to be applied to the capillary.
  7. The microinjection device according to claim 3, wherein the regulator includes a double system of regulators to maintain constant pressure, and the regulating chamber includes a double system of regulating chambers to maintain the internal pressure to a predetermined pressure.
EP20070105503 2006-05-12 2007-04-02 Method and device for injecting a solution into a cell Expired - Fee Related EP1854874B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006133512A JP5011812B2 (en) 2006-05-12 2006-05-12 Method for discharging liquid into cell and microinjection apparatus

Publications (2)

Publication Number Publication Date
EP1854874A1 true EP1854874A1 (en) 2007-11-14
EP1854874B1 EP1854874B1 (en) 2010-06-09

Family

ID=38235404

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20070105503 Expired - Fee Related EP1854874B1 (en) 2006-05-12 2007-04-02 Method and device for injecting a solution into a cell

Country Status (5)

Country Link
US (1) US8012417B2 (en)
EP (1) EP1854874B1 (en)
JP (1) JP5011812B2 (en)
KR (1) KR100870167B1 (en)
DE (1) DE602007007011D1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010035457A (en) * 2008-08-01 2010-02-18 Fujitsu Ltd Injection device and method of injection by using the same
JP5272633B2 (en) * 2008-10-06 2013-08-28 富士通株式会社 Injection device
JP5141543B2 (en) * 2008-12-25 2013-02-13 富士通株式会社 Microinjection apparatus and backflow prevention pressure measuring method

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2114740A (en) * 1982-02-05 1983-08-24 Europ Lab Molekularbiolog Method and apparatus for injecting miniscule quantities of samples into cells
JPH03119989A (en) 1989-10-02 1991-05-22 Toshiro Higuchi Micro-injector and method for controlling injection thereof
JPH04304881A (en) * 1991-03-29 1992-10-28 Shimadzu Corp Equipment for injection
WO1993007256A1 (en) * 1991-10-07 1993-04-15 Ciba-Geigy Ag Particle gun for introducing dna into intact cells
DE4401076A1 (en) 1994-01-15 1995-07-20 Eppendorf Geraetebau Netheler Injection appts. for biological cells

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62224361A (en) * 1986-03-26 1987-10-02 アイシン精機株式会社 Auxiliary circulation machinery driving apparatus
JP2513359B2 (en) * 1990-11-30 1996-07-03 株式会社島津製作所 Micro pipette device
US5456880A (en) * 1992-11-20 1995-10-10 Shimadzu Corporation Micropipet apparatus and micromanipulator
JP2003186549A (en) * 2001-10-12 2003-07-04 Smc Corp Fluid pressure regulator
US6779541B2 (en) * 2001-10-12 2004-08-24 Smc Kabushiki Kaisha Fluid pressure regulator
US6958043B2 (en) * 2002-05-21 2005-10-25 Medtronic Xomed, Inc. Apparatus and method for displacing the partition between the middle ear and the inner ear using a manually powered device
JP4278365B2 (en) 2002-11-22 2009-06-10 富士通株式会社 Transduced cell production device
CN1950124B (en) * 2004-01-12 2010-11-10 Ⅰ科学外科公司 Injector for viscous materials
JP4456429B2 (en) * 2004-07-27 2010-04-28 富士通株式会社 Injection device
KR100597814B1 (en) * 2005-10-31 2006-07-10 (주)엠큐어 Pneumatic injection gun

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2114740A (en) * 1982-02-05 1983-08-24 Europ Lab Molekularbiolog Method and apparatus for injecting miniscule quantities of samples into cells
JPH03119989A (en) 1989-10-02 1991-05-22 Toshiro Higuchi Micro-injector and method for controlling injection thereof
JPH04304881A (en) * 1991-03-29 1992-10-28 Shimadzu Corp Equipment for injection
WO1993007256A1 (en) * 1991-10-07 1993-04-15 Ciba-Geigy Ag Particle gun for introducing dna into intact cells
DE4401076A1 (en) 1994-01-15 1995-07-20 Eppendorf Geraetebau Netheler Injection appts. for biological cells

Also Published As

Publication number Publication date
JP2007300868A (en) 2007-11-22
DE602007007011D1 (en) 2010-07-22
KR100870167B1 (en) 2008-11-25
JP5011812B2 (en) 2012-08-29
US8012417B2 (en) 2011-09-06
US20070264162A1 (en) 2007-11-15
EP1854874B1 (en) 2010-06-09
KR20070109832A (en) 2007-11-15

Similar Documents

Publication Publication Date Title
EP1841963B1 (en) Method for operating a fuel injection device of an internal combustion engine
DE102012209314B4 (en) Device and method for dispensing or receiving a liquid volume
US8631785B2 (en) Method for detecting deviations of injection quantities and for correcting the injection quantity, and injection system
CN104696706A (en) Micro fluid flow adjusting device based on air pressure drive
DE102014100489B4 (en) Fuel injector
US8433498B2 (en) Method and system for controlling fuel pressure
WO2000024526A1 (en) Liquid constant rate discharge method and device
EP1854874A1 (en) Method and device for injecting a solution into a cell
CN104105861B (en) For carrying out pressure controlled method in the high-pressure area of internal combustion engine
US10253712B2 (en) Method for operating a piezo servo injector
EP1562093A2 (en) Dosing device
CN109212246A (en) Liquid feed device, sample analyser build pressure device and feed liquid method
EP2105606A1 (en) Direct injection assembly of the common-rail type provided with a shut-off valve for controlling the delivery of a high-pressure fuel pump
CN111185347A (en) Quantitative discharge device
CN102818054A (en) Assistance type pin type back-pressure control method and back-pressure valve thereof
JP4992369B2 (en) Discharge amount control method, discharge pressure control method, injection device, method for manufacturing microscopic object, discharge amount control device, and discharge amount control program
JP2006197880A (en) Apparatus for catching cell and method for catching cell
DE102015224622A1 (en) FREISTRAHLDOSIERSYSTEM
DE10149671A1 (en) Method for controlling a piezo drive and piezo drive for performing the method
US20120166067A1 (en) Method for controlling a fuel injector
JP2006525455A (en) Method and apparatus for determining the charging edge of a piezoelectric actuator
DE102007013772B4 (en) Method for controlling an injection system of an internal combustion engine
JP2021530281A (en) Methods and systems for delivering substances to body parts
JP2003514592A (en) Flow control members used in liquid dispensers
CN107907318A (en) The test method and system of a kind of fuel metering valve

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK YU

17P Request for examination filed

Effective date: 20080325

AKX Designation fees paid

Designated state(s): DE FR GB

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): DE FR GB

REF Corresponds to:

Ref document number: 602007007011

Country of ref document: DE

Date of ref document: 20100722

Kind code of ref document: P

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602007007011

Country of ref document: DE

Effective date: 20110309

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20140402

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20141231

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140402

REG Reference to a national code

Ref country code: FR

Ref legal event code: RN

Effective date: 20150120

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20140430

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 9

REG Reference to a national code

Ref country code: FR

Ref legal event code: FC

Effective date: 20151019

REG Reference to a national code

Ref country code: GB

Ref legal event code: S28

Free format text: APPLICATION FILED

REG Reference to a national code

Ref country code: GB

Ref legal event code: S28

Free format text: RESTORATION ALLOWED

Effective date: 20160105

PGRI Patent reinstated in contracting state [announced from national office to epo]

Ref country code: FR

Effective date: 20151109

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 10

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 11

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20190313

Year of fee payment: 13

Ref country code: GB

Payment date: 20190327

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20190319

Year of fee payment: 13

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 602007007011

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201103

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200430

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20200402

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200402